BioPharma Conference is a Success for Faithful+Gould

Christy Ullo
Thirty senior figures from some of the world's leading pharmaceutical and biotechnology companies came together recently for Faithful+Gould's one-day biopharmaceutical conference in London.

In October, Faithful+Gould facilitated its 2008 Biopharmaceuticals Conference, held at the Institute of Directors in London. Thirty pharmaceutical and biotechnology clients, senior figures within their organizations, came together to discuss best practice in the program and project management of their planned investments.

The event focused on sharing best practice, looking at where the industry is going and how the organizations can maximize planned investments.

Presentations were given by Faithful+Gould's global biopharmaceutical team and clients from AstraZeneca and GlaxoSmithKline, with interactive workshops taking place throughout the day.


Members of the BioPharmaceutical Conferernce in London
Industry leaders share best practice during the Biopharmaceutical Conference in London


Bruce Davis, Chair of International Society for Pharmaceutical Engineering (ISPE) commented, "This forum brought about a significant meeting of minds and exchange of ideas. It was an excellent opportunity to network, share best practice and explore common challenges and constraints about managing projects in a variety of global locations."

Faithful+Gould is long established in this Pharmaceutical+Biotechnology sector. We are located in every primary location in the global biopharmaceuticals market, and continue to work closely with the industry leaders. Following the success of this event, our next biopharmaceuticals conference is scheduled for Spring+Summer 2009 in New York.

For further information please contact Iain McWhinney in our Princeton office at 1.609.514.0900 or